Letter to the Editor: indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus

• Nick Ballew,
• Aneela Mian,
• Roger Abramino Levy,
• Matt Bradley

Affiliations

Nick Ballew

ORCiD

GSK, Value Evidence & Outcomes, Collegeville, PA 19426, USA

Aneela Mian

GSK, Global Medical Affairs, Brentford, Middlesex, UK

Roger Abramino Levy

GSK, Specialty Care, Global Medical Affairs, Collegeville, PA 19426, USA

Matt Bradley

GSK, Value Evidence & Outcomes, Brentford, Middlesex, UK